Long COVID’s Cardio Referrals; Ross Procedure Shines; Cough Medicine for Long QT?

A look at long COVID’s impact on the heart in the Washington Post.

What would a good model for referring long COVID patients to cardiac services look like? (European Heart Journal)

The U.S. Preventive Services Task Force maintains its recommendations on statins for primary prevention in a draft statement.

Fewer than 1 in 5 eligible people are taking statins in low- and middle-income countries. (The Lancet Global Health)

Young adults fared better more than a decade after a Ross procedure than surgical aortic valve replacement with biological and mechanical devices, state registries show. (Journal of the American College of Cardiology)

A few years after coronary artery bypass grafting (CABG), there was faster progression of atherosclerosis in native coronary arteries that had been bypassed than those that hadn’t been. (JACC: Cardiovascular Imaging)

Off-pump surgery did not confer better outcomes 10 years after CABG in the ROOBY trial. (JAMA Surgery)

Meta-analysis favors more intensive LDL cholesterol lowering to prevent recurrent strokes. (JAMA Neurology)

For people with anterior circulation large vessel occlusion strokes, IV thrombolysis and mechanical thrombectomy together, or bridging therapy, came out on top in a meta-analysis. (Neurology)

Expect the upcoming VALOR-HCM trial report to support mavacamten treatment for people with obstructive hypertrophic cardiomyopathy who are candidates for septal reduction, according to Bristol Myers Squibb.

FDA gave the greenlight to expanded approval for the CardioMEMS pulmonary pressure sensor to include class II heart failure patients, Abbott announced.

Medtronic said its Freezor and Freezor Xtra cryoablation catheters got expanded FDA approval for pediatric atrioventricular nodal reentrant tachycardia.

The burden of ventricular tachycardia (VT) was reduced after noninvasive transcutaneous magnetic stimulation of the left stellate ganglion, according to a small double-blind, sham-controlled trial in patients with VT storm. (JAMA Cardiology)

Heart attack survivors were less likely to develop Parkinson’s disease than the general population, a Danish study found. (Journal of the American Heart Association)

Cough suppressant dextromethorphan showed promise as a treatment for long QT syndrome in a mouse study. (Nature Cardiovascular Research)

Male mice were particularly susceptible to the cardiac harms of vaping. (Circulation)

Pediatric cardiologist Jeff Zampi, MD, recently saved a friend in cardiac arrest in the middle of a hockey game, according to a report from University of Michigan’s University Record.